7/16/2025

Dextroamphetamine Extended-Release Capsules

Products Affected - Description

- Dextroamphetamine sulfate oral extended release capsule, Teva, 10 mg, bottle, 90 count, NDC 45963-0304-09
- Dextroamphetamine sulfate oral extended release capsule, Teva, 15 mg, bottle, 90 count, NDC 45963-0305-09
- Dextroamphetamine sulfate oral extended release capsule, Teva, 5 mg, bottle, 90 count, NDC 45963-0303-09

Reason for the Shortage

- Amneal has Dexedrine Spansule capsules available.
- Mallinckrodt refuses to provide availability information.
- Teva did not provide a reason for the shortage.

Available Products

- Dexedrine Spansule oral extended release capsule, Amneal, 10 mg, bottle, 90 count, NDC 64896-0674-10

Estimated Resupply Dates

- Teva has dextroamphetamine extended-release capsules available with short expiration dating (July 2025).

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.